Vote Scores
Filings read through

Karuna Therapeutics, Inc.: how funds voted at the meeting of 12 Mar 2024

Meeting
Season
year to 30 June 2024
Filers reporting
451
Ballot items
3

451 filers on Form N-PX reported votes at the Karuna Therapeutics, Inc. meeting of 12 Mar 2024. The records fall into 3 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2024. The latest season on file is the year to 30 June 2026. The page of Karuna Therapeutics, Inc. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2024. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Advisory vote on executive pay (say-on-pay)

    647 vote records from 439 filers. 128 of the 424 filers that marked the item voted against management. 15 filers gave no management mark.

    2 filers reported share counts too large for the holding. The share split leaves those figures out; the counts of filers keep them. The rule

    • Positions of 44 fund families
    • For 28
    • Against 15
    • Abstain or withhold 1
    • Against management 16
  2. Item 2: EXTRAORDINARY TRANSACTIONS: management items

    The company's items in this category are shown together, because filers word and number them differently.

    257 vote records from 144 filers. 0 of the 144 filers that marked the item voted against management.

    • Positions of 38 fund families
    • For 38
  3. Item 3: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    348 vote records from 170 filers. 26 of the 170 filers that marked the item voted against management.

    • Positions of 41 fund families
    • For 35
    • Against 6
    • Against management 6

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Karuna Therapeutics, Inc., meeting of 12 Mar 2024Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family1. Say-on-pay
AllianceBernsteinAgainst, against management
AllspringFor
American CenturyFor
BlackRock and iSharesFor
BNY MellonFor
Brighthouse FundsFor
Capital Group and American FundsAgainst, against management
Charles SchwabAgainst, against management
Columbia ThreadneedleFor
DimensionalAgainst, against management
DWSFor
EquitableAgainst, against management
FidelityFor
First TrustFor
Franklin TempletonFor
Goldman SachsFor
Guggenheim and RydexFor
Hartford FundsFor
InvescoFor
J.P. MorganFor
Jackson National fundsAgainst, against management
Janus HendersonFor
John Hancock and ManulifeAgainst, against management
Lincoln FinancialFor
MassMutualAgainst, against management
Morgan Stanley, Eaton Vance and CalvertFor
NationwideFor
Natixis and Loomis SaylesAgainst, against management
Neuberger BermanAgainst, against management
Northern Trust and FlexSharesFor
Nuveen and TIAAAgainst, against management
Pacific Life fundsFor
PGIM and PrudentialAgainst, against management
PIMCOFor
PrincipalFor
ProShares and ProFundsFor
SEIAgainst, against management
State Street and SPDRFor
T. Rowe PriceAgainst, against management
TransamericaAgainst, against management
VanguardFor
Victory CapitalFor
VirtusFor
VoyaAbstain, against management

Questions

How many filers reported votes at the Karuna Therapeutics, Inc. meeting?
451 Form N-PX filers reported votes at the meeting of 12 Mar 2024. On say-on-pay, 128 of 424 filers that marked the item voted against management (30.2%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Karuna Therapeutics, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Karuna Therapeutics, Inc. with a meeting date within three days of 12 Mar 2024. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .